The role of trust in the likelihood of receiving a COVID-19 vaccine: Results from a national survey.

The role of trust in the likelihood of receiving a COVID-19 vaccine: Results from a national survey.
复制标题

DOI:
10.1016/j.ypmed.2021.106727
复制
发表时间:
2021-12
影响因子:
5.1
通讯作者:
Kapteyn A
Kapteyn A
中科院分区:
医学2区
文献类型:
--
作者:
Szilagyi PG;Thomas K;Shah MD;Vizueta N;Cui Y;Vangala S;Fox C;Kapteyn A

文献摘要

参考文献

被引文献

相似文献

High acceptance of coronavirus disease 2019 (COVID-19) vaccines is instrumental to ending the pandemic. Vaccine acceptance by subgroups of the population depends on their trust in COVID-19 vaccines. We surveyed a probability-based internet panel of 7832 adults from December 23, 2020–January 19, 2021 about their likelihood of getting a COVID-19 vaccine and the following domains of trust: an individual's generalized trust, trust in COVID-19 vaccine's efficacy and safety, trust in the governmental approval process and general vaccine development process for COVID-19 vaccines, trust in their physician about COVID-19, and trust in other sources about COVID-19. We included identified at-risk subgroups: healthcare workers, older adults (65–74-year-olds and ≥ 75-year-olds), frontline essential workers, other essential workers, and individuals with high-risk chronic conditions. Of 5979 respondents, only 57.4% said they were very likely or somewhat likely to get a COVID-19 vaccine. More hesitant respondents (p < 0.05) included: women, young adults (18–49 years), Blacks, individuals with lower education, those with lower income, and individuals without high-risk chronic conditions. Lack of trust in the vaccine approval and development processes explained most of the demographic variation in stated vaccination likelihood, while other domains of trust explained less variation. We conclude that hesitancy for COVID-19 vaccines is high overall and among at-risk subgroups, and hesitancy is strongly tied to trust in the vaccine approval and development processes. Building trust is critical to ending the pandemic.
DOI: 10.1177/1075547020960463
发表时间: 2020-10
影响因子: 9
作者:
Head KJ;Kasting ML;Sturm LA;Hartsock JA;Zimet GD
通讯作者: Zimet GD
DOI: 10.7326/m20-3569
发表时间: 2020-12-15
影响因子: 39.2
作者:
Fisher, Kimberly A.;Bloomstone, Sarah J.;Mazor, Kathleen M.
通讯作者: Mazor, Kathleen M.
DOI: 10.1177/1529100618760521
发表时间: 2017-12-01
影响因子: 25.4
作者:
Brewer, Noel T.;Chapman, Gretchen B.;Kempe, Allison
通讯作者: Kempe, Allison
DOI: 10.1001/jamanetworkopen.2020.25594
发表时间: 2020-10-01
期刊: JAMA network open
影响因子: 13.8
作者:
Kreps S;Prasad S;Brownstein JS;Hswen Y;Garibaldi BT;Zhang B;Kriner DL
通讯作者: Kriner DL
DOI: 10.1542/peds.2016-2146
发表时间: 2016-09-01
期刊: PEDIATRICS
影响因子: 8
作者:
Edwards, Kathryn M.;Hackell, Jesse M.
通讯作者: Hackell, Jesse M.